Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial
Najib U, Smith T, Hindiyeh N, Saper J, Nye B, Ashina S, McClure CK, Marmura MJ, Chase S, Liebler E, et al.
Cephalalgia · 2022
Key finding
Active nVNS achieved a 44.87% responder rate versus 26.81% for sham (P=0.048), with migraine with aura patients showing a therapeutic gain exceeding 100% over sham.
- Condition
- Migraine
- Stimulation
- tcVNS
- Evidence tier
- Randomised Controlled Trial
- Participants
- 336
Cite this study
Najib, U., Smith, T., Hindiyeh, N., Saper, J., Nye, B., Ashina, S., McClure, C. K., Marmura, M. J., Chase, S., Liebler, E., & Lipton, R. B. (2022). Non-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial. Cephalalgia, 42(7), 560-569. https://doi.org/10.1177/03331024211068813
Related studies in Migraine
Effectiveness of non-invasive vagus nerve stimulation vs heart rate variability biofeedback interventions for chronic pain conditions: A systematic review
Pellow et al. · Scandinavian journal of pain · 2025 · Systematic Review / Meta-Analysis
Clinical Efficacy of Auricular Vagus Nerve Stimulation in the Treatment of Chronic and Acute Pain: A Systematic Review and Meta-analysis
Duff et al. · Pain and therapy · 2024 · Systematic Review / Meta-Analysis
[Clinical efficacy of auricular vagus nerve stimulation in the treatment of chronic and acute pain : A systematic review]
Likar et al. · Schmerz (Berlin, Germany) · 2024 · Systematic Review / Meta-Analysis
Transcutaneous vagus nerve stimulation effects on chronic pain: systematic review and meta-analysis
Costa et al. · Pain reports · 2024 · Systematic Review / Meta-Analysis
Summary by Vagus Research. Always consult the primary source for the authoritative record.